:max_bytes(133120)/d1qcnx2r3xkirq.cloudfront.net/pubmed-llm-images/40214467/22661e9c4c828e78102770844201ec8e_wm.png)
Prostate-Specific Membrane Antigen-Targeted Antibody-Drug Conjugates: A Promising Approach for Metastatic Castration-Resistant Prostate Cancer.
Summary: Prostate cancer can be very hard to treat when it spreads and stops responding to standard hormone treatments. Scientists are looking at a new way to fight it using a special tool called an Antibody-Drug Conjugate, or ADC. Think of an ADC like a smart bomb. It finds a specific marker on the cancer cells called PSMA, locks on, and delivers medicine right inside the tumor. This helps kill the cancer while keeping healthy parts of the body safe. Early tests show that these smart bombs are working well and have side effects that doctors can manage. While more testing is needed, this new treatment offers great hope for men with advanced prostate cancer!
Tags
Prostatic Neoplasms
Urinary Bladder Neoplasms
Neoplasms
Carcinoma